Brian D. Keane

CEO at Callitas Therapeutics

Brian D. Keane joined as CEO in December 2019 and Director in February 2021. He has over 25 years of Legal, Capital Markets and Investing experience. He specializes in originating, advising, and investing in emerging growth companies in the US, Canada, Caribbean and Asia. He has participated in over 100 investments, totaling over $2.5 Billion across every major industry. As an early investor and advisor in the Legal Cannabis space, He brings extensive knowledge and networks to implement and scale IP and product Strategy for the Company

He is an advisor to Multiple Family Offices, Founder of Qualified Capital and 420 Acquisitions, LLC, Founding board member of 1933 Industries, CSE:TGIF and several other private and public companies, including board of director at American CBD Extraction (Sold to Thoughtful Brands), Codebase Ventures, Weekend Unlimited Industries, founding advisor to Supreme Cannabis Co. Previously, he has advised and managed several investment funds and Investment Banks, that include: Paragon Capital, LP, Keating Capital, Four Springs Capital, Yorkville Advisors, Merriman Capital, Inc, Rodman & Renshaw, LLC, (now HC Wainwright), Ladenburg Thalmann & Co. and Techvest LLC (acquired by Rodman). He began his career as an equity trader for NDB Group, NYSE:NDB (acquired by Deutsche Bank) He holds a BS from the University of Scranton 1997 and a JD from New York Law School 2000 and was previously licensed Series 7,55,63,79

Org chart

Timeline

  • CEO

    Current role

View in org chart